Literature DB >> 8642640

The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection.

M L Mirsky1, C A Olmstead, Y Da, H A Lewin.   

Abstract

The bovine leukemia virus (BLV) is an oncogenic retrovirus that is associated with the development of persistent lymphocytosis (PL) and lymphoma in cattle. While B lymphocytes have been shown to be the primary cellular target of BLV, recent studies suggest that some T lymphocytes and monocytes may be infected by the virus. Because virally altered functions of monocytes and/or T cells could contribute to the development of lymphoproliferative disease, we sought to clarify the distribution of the BLV provirus in subpopulations of peripheral blood mononuclear cells in seropositive cows with and without PL. CD2+ T cells, monocytes, and CD5+ and CD5- B cells were sorted by flow cytometry and tested for the presence of BLV by single-cell PCR. We did not obtain convincing evidence that peripheral blood monocytes or T lymphocytes contain the BLV provirus in seropositive cows with or without PL. In seropositive cows without PL (n=14), BLV-infected CD5+ and CD5- B cells accounted for 9.2% +/- 19% and 0.1% +/- 1.8% of circulating B lymphocytes, respectively. In cows with PL (n=5), BLV-infected CD5+ and CD5- B cells accounted for 66% +/- 4.8% and 13.9% +/- 6.6% of circulating B lymphocytes, respectively. The increase in lymphocyte numbers in cows with PL was entirely attributable to the 45-fold and 99-fold expansions of infected CD5+ and CD5- B-cell populations, respectively. Our results demonstrate that B cells are the only mononuclear cells in peripheral blood that are significantly infected with BLV. On the basis of the absolute numbers of infected cells in seropositive, hematologically normal animals, there appear to be differences in susceptibility to viral spread in vivo that may be under the genetic control of the host.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642640      PMCID: PMC190056     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  PEDIGREE STUDIES IN BOVINE LYMPHOSARCOMA.

Authors:  J E CROSHAW; D A ABT; R R MARSHAK; W C HARE; J SWITZER; J IPSEN; R M DUTCHER
Journal:  Ann N Y Acad Sci       Date:  1963-11-04       Impact factor: 5.691

2.  Criteria for the determination of the normal and leukotic state in cattle.

Authors: 
Journal:  J Natl Cancer Inst       Date:  1968-07       Impact factor: 13.506

3.  Virus-like particles in phytohemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma.

Authors:  J M Miller; L D Miller; C Olson; K G Gillette
Journal:  J Natl Cancer Inst       Date:  1969-12       Impact factor: 13.506

Review 4.  Bovine lymphosarcoma.

Authors:  J F Ferrer
Journal:  Adv Vet Sci Comp Med       Date:  1980

5.  Bovine leukemia virus: an exogenous RNA oncogenic virus.

Authors:  R Kettmann; D Portetelle; M Mammerickx; Y Cleuter; D Dekegel; M Galoux; J Ghysdael; A Burny; H Chantrenne
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

Review 6.  Persistent lymphocytosis in cattle: its cause, nature and relation to lymphosarcoma.

Authors:  J F Ferrer; R R Marshak; D A Abt; S J Kenyon
Journal:  Ann Rech Vet       Date:  1978

7.  Bovine hematology. III. Comparative breed studies on the leukocyte parameters of several European cattle breeds as determined in the common reference laboratory.

Authors:  M Mammerickx; R J Lorenz; O C Straub; W J Donnelly; J C Flensburg; G Gentile; L M Markson; A A Ressang; S M Taylor
Journal:  Zentralbl Veterinarmed B       Date:  1978-05

8.  Cellular basis of persistent lymphocytosis in cattle infected with bovine leukemia virus.

Authors:  S J Kenyon; C E Piper
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

9.  Evidence for the replication of bovine leukemia virus in the B lymphocytes.

Authors:  P S Paul; K A Pomeroy; D W Johnson; C C Muscoplat; B S Handwerger; F F Soper; D K Sorensen
Journal:  Am J Vet Res       Date:  1977-06       Impact factor: 1.156

10.  Genomic integration of bovine leukemia provirus: comparison of persistent lymphocytosis with lymph node tumor form of enzootic.

Authors:  R Kettmann; Y Cleuter; M Mammerickx; M Meunier-Rotival; G Bernardi; A Burny; H Chantrenne
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more
  40 in total

1.  Assessment of bovine leukemia virus transcripts in vivo.

Authors:  J Rovnak; J W Casey
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Discordance between bovine leukemia virus tax immortalization in vitro and oncogenicity in vivo.

Authors:  J C Twizere; P Kerkhofs; A Burny; D Portetelle; R Kettmann; L Willems
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Intestinal Shiga toxin-producing Escherichia coli bacteria mitigate bovine leukemia virus infection in experimentally infected sheep.

Authors:  Witold A Ferens; Rowland Cobbold; Carolyn J Hovde
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

4.  Dissemination of bovine leukemia virus-infected cells from a newly infected sheep lymph node.

Authors:  B E Fulton; M Portella; K Radke
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus.

Authors:  D Pyeon; F J Diaz; G A Splitter
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  Bovine leukemia virus-induced lymphocytosis and increased cell survival mainly involve the CD11b+ B-lymphocyte subset in sheep.

Authors:  N Chevallier; M Berthelemy; D Le Rhun; V Lainé; D Levy; I Schwartz-Cornil
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  CD154 costimulated ovine primary B cells, a cell culture system that supports productive infection by bovine leukemia virus.

Authors:  A Van den Broeke; Y Cleuter; T Beskorwayne; P Kerkhofs; M Szynal; C Bagnis; A Burny; P Griebel
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  Shiga toxin 1 targets bovine leukemia virus-expressing cells.

Authors:  Witold A Ferens; Luke J Grauke; Carolyn J Hovde
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 9.  Hematopoietic stem cells and retroviral infection.

Authors:  Prabal Banerjee; Lindsey Crawford; Elizabeth Samuelson; Gerold Feuer
Journal:  Retrovirology       Date:  2010-02-04       Impact factor: 4.602

10.  Low numbers of intestinal Shiga toxin-producing E. coli correlate with a poor prognosis in sheep infected with bovine leukemia virus.

Authors:  Witold A Ferens; Julius Haruna; Rowland Cobbold; Carolyn J Hovde
Journal:  J Vet Sci       Date:  2008-12       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.